
Dolby Laboratories Stock Plummets to New 52-Week Low at $64.23
2025-11-18 16:59:46Dolby Laboratories, Inc. has hit a new 52-week low, reflecting an 18.4% decline in stock price over the past year. The company faces financial challenges, including decreased profits and stagnant growth, while its market capitalization is approximately USD 7 billion. Institutional holdings remain high at 100%.
Read More
Dolby Laboratories Stock Plummets to New 52-Week Low at $64.38
2025-11-10 17:15:00Dolby Laboratories, Inc. has reached a 52-week low, trading at USD 64.38 as of November 7, 2025, following a 17.7% decline in stock price over the past year. The company faces challenges with declining profits and flat sales growth, despite strong institutional interest and a notable market capitalization.
Read More
Dolby Laboratories Stock Hits 52-Week Low at $64.50
2025-10-31 16:17:38Dolby Laboratories, Inc. has hit a new 52-week low, trading at USD 64.50 as of October 30, 2025. The company has experienced a 17% decline in stock price over the past year, with recent financial results showing significant decreases in pre-tax and net profits, alongside flat sales growth.
Read More
Dolby Laboratories Hits New 52-Week Low at $64.56 Amid Declining Sales
2025-10-30 18:39:21Dolby Laboratories, Inc. has hit a new 52-week low, trading at USD 64.56. The company, with a market capitalization of USD 7,024 million, faces challenges including declining profits and modest sales growth. Its financial metrics reveal a P/E ratio of 27.00 and a low cash position of USD 1,507.67 million.
Read More
Dolby Laboratories Stock Hits 52-Week Low at $67.10
2025-10-23 17:08:01Dolby Laboratories, Inc. has hit a new 52-week low, with its stock price declining significantly over the past year. The company reported decreases in pre-tax and net profits, while cash reserves have also diminished. Despite flat growth in sales and operating profit, institutional investors have shown increased interest.
Read MoreIs Dolby Laboratories, Inc. overvalued or undervalued?
2025-10-21 12:06:41As of 17 October 2025, the valuation grade for Dolby Laboratories, Inc. has moved from very attractive to attractive. The company appears to be overvalued based on its current metrics. The P/E ratio stands at 27, which is significantly higher than its peer average of approximately 25.89. Additionally, the EV to EBITDA ratio of 17.08 also exceeds the peer average of 16.20, while the PEG ratio of 2.73 indicates that the stock may be overvalued relative to its growth prospects. In comparison to its peers, Dolby's valuation ratios suggest a premium position, especially when juxtaposed with Duolingo, Inc., which has a P/E of 104.90, and Qualys, Inc., with a P/E of 25.97. The stock has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -11.97% compared to the index's 13.30%, reinforcing the notion that Dolby may be overvalued in the current market environment....
Read More
Dolby Laboratories, Inc. Experiences Revision in Stock Evaluation Amid Competitive Software Landscape
2025-10-20 15:53:43Dolby Laboratories, Inc. has recently adjusted its valuation, with a P/E ratio of 27 and a price-to-book value of 2.80. Key financial metrics include an EV to EBIT of 22.83 and a PEG ratio of 2.73, showcasing its operational efficiency and competitive position within the software industry.
Read MoreIs Dolby Laboratories, Inc. overvalued or undervalued?
2025-10-20 12:24:02As of 17 October 2025, the valuation grade for Dolby Laboratories, Inc. has moved from very attractive to attractive, indicating a shift in perceived value. Based on the current metrics, the company appears to be fairly valued. Key ratios include a P/E ratio of 27, an EV to EBITDA of 17.08, and a Price to Book Value of 2.80, which suggest that while the company is not undervalued, it is also not excessively priced compared to its peers. In comparison to its peers, Dolby's P/E ratio of 25.89 is lower than that of Duolingo, Inc., which has a P/E of 104.90, indicating that Dolby is more attractively priced relative to this competitor. Additionally, Qualys, Inc. has a similar P/E of 25.97, reinforcing the notion that Dolby is positioned competitively within its industry. Notably, over the past year, Dolby has underperformed the S&P 500, returning -7.17% compared to the index's 14.08%, which may further support...
Read MoreIs Dolby Laboratories, Inc. overvalued or undervalued?
2025-10-19 12:01:37As of 17 October 2025, the valuation grade for Dolby Laboratories, Inc. has moved from very attractive to attractive, indicating a shift in perceived value. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 27, which is higher than its peer average of approximately 25.9 for Dolby and 25.97 for Qualys, Inc. Additionally, the EV to EBITDA ratio stands at 17.08, which is also above the peer average of 16.2, suggesting that the stock may be priced too high relative to its earnings potential. In comparison to its peers, Dolby's valuation ratios indicate a premium, especially when contrasted with Duolingo, Inc., which has a significantly higher P/E ratio of 104.9, and Informatica, Inc., which is considered risky with a P/E ratio of 1253.8. Moreover, the company's recent stock performance has been underwhelming, with a year-to-date return of -11.97% compared to th...
Read More





